The experimental drug, known as ZMapp, was developed by the biotech firm Mapp Biopharmaceutical Inc., which is based in San Diego
Trending
- CSO faults US Mission’s position on Edo governorship poll
- Abia governor condemns attack on Chinese miners
- APC seeks security agencies’ intervention in Osun LG crisis
- Assassination allegation: Group gives Akpoti-Uduaghan seven days to produce evidence
- ACF to FG: Act now on Plateau killings
- AFDEIC 2025: Conference to focus on Africa’s $180bn digital economy, Artificial intelligence
- Kano Eid-el-fitr Killing: Police withdraw invitation letter to Emir Sanusi
- PDP, Ighodalo insist on challenging tribunal decision after studying judgment CTC
